Gradient vs Isocratic Elution in Peptide HPLC
The mobile phase either stays the same for the whole run or it changes. That single decision determines how sharp the peaks are, how well neighbouring impurities separate, and what a purity figure can honestly claim.
In HPLC, isocratic elution uses a mobile phase of constant composition for the whole run. Gradient elution changes the composition during the run, usually by raising the proportion of organic solvent. Peptides are almost always analysed by gradient elution. Their retention is highly sensitive to solvent strength, and a typical sample holds components of very different hydrophobicity. Isocratic elution is the better tool when the components are few and similar.
This looks like a minor method detail. It is not. The choice decides whether an impurity appears as its own peak or hides under the main one. It also changes retention times, baseline shape and the purity figure on a certificate. Understanding it makes a chromatogram much easier to read.
How reversed-phase separation works
Most peptide purity work uses reversed-phase HPLC. The column is packed with a non-polar stationary phase, commonly a bonded alkyl chain on silica. The mobile phase is polar. Peptides stick to the stationary phase through hydrophobic interaction, and the mobile phase pulls them off again.
The mobile phase is normally two solutions mixed by the pump:
- Mobile phase A: water, with an ion-pairing acid such as trifluoroacetic acid (TFA), often at about 0.1%.
- Mobile phase B: an organic solvent, most often acetonitrile, usually with the same acid, sometimes at a slightly different level to flatten the baseline.
The pump mixes A and B in changing proportions. More B means a stronger mobile phase, and strongly retained peptides then release from the column. The percentage of B is written %B. Each peptide elutes when the %B around it becomes strong enough to move it along the column.
The acid does real work. It keeps the peptide in a consistent ionisation state and pairs with charged groups, which usually sharpens peaks. Lower acid levels commonly give poorer peak shape and reduced resolution. Changing the acid also changes selectivity, so it is part of the method.
What isocratic elution does
In an isocratic run the %B is fixed. A run at 30% B stays at 30% B from injection to the end. Every component experiences the same solvent strength for the entire time it is on the column.
This has real advantages. The method is simple. The pump needs only to deliver a steady mixture. The UV baseline is flat. The column is already in its working state when the run ends, so the next injection can follow immediately.
The limit is that one solvent strength has to suit every component. If it is weak enough to separate the early peaks, the late ones may take very long to leave and emerge as low, broad humps. If it is strong enough to move the late peaks promptly, the early ones may crowd together near the void volume with no resolution.
The general elution problem
This trade-off has a name: the general elution problem. A single isocratic condition rarely gives good separation across a sample whose components span a wide range of retention. Some components are held too weakly, others too strongly, and no single %B is right for all of them.
Gradient elution is the standard answer. It starts weak, so early components are retained and separated. It then strengthens, so later components are pushed off the column in a reasonable time. Because the stronger solvent arrives from the column inlet, the rear of a band is exposed to a higher %B than its front. The rear therefore moves slightly faster and catches up with the front. That compresses the band, which tends to give narrower peaks for late-eluting compounds than isocratic elution would.
Why peptides need a gradient
Two properties of peptides make the general elution problem severe.
Retention changes steeply with %B. For many small molecules, retention falls gradually as organic solvent rises. For peptides the change is much sharper. A modest shift in %B can swing a peptide from strongly held to nearly unretained. Under isocratic conditions this makes the method fragile. A small error in mixing the mobile phase produces a large change in retention time.
A real sample is a mixture across a hydrophobicity range. The target peptide is not alone. Synthesis and storage can produce truncated sequences, deletion sequences, oxidised forms, deamidated forms and other related substances. These differ from the main peptide in hydrophobicity, sometimes slightly and sometimes a lot. A method that is meant to reveal them must hold the polar ones long enough to separate and still elute the hydrophobic ones as measurable peaks. A gradient does both in one run.
The result is that peptide peaks under a gradient tend to be narrow, while under isocratic conditions they tend to be broad and variable. Narrow peaks are easier to integrate and show more clearly when a small impurity sits near a large one.
Peak capacity and resolution
Two terms matter here.
- Resolution describes how well two neighbouring peaks are separated. It depends on how far apart their centres are and how wide the peaks are.
- Peak capacity is the number of peaks that could, in principle, be separated side by side within a run. Gradients generally give much higher peak capacity than isocratic runs of the same length, because peaks stay narrow across the whole window.
Peak capacity is a ceiling, not a guarantee. A real sample does not space its components evenly, so some regions of the chromatogram are crowded while others are empty. Resolution between a specific pair still has to be demonstrated.
How gradient slope moves retention and resolution
The gradient slope is how fast %B rises, for example a given number of percentage points per minute. It is the main control a method developer has.
- A shallower gradient raises %B slowly. Peaks usually spread further apart in time, so closely related components separate better. The run is longer and individual peaks are often a little broader.
- A steeper gradient raises %B quickly. Retention times fall, peaks are sharper and the run is shorter. Components that were just resolved may now merge.
The starting %B and the final %B matter as well. A start that is too high loses the early-eluting impurities in the void region. A range that ends too low can leave very hydrophobic material on the column.
Retention under a gradient is also a different quantity from retention under isocratic conditions. In a gradient, a peptide elutes at a particular %B, and its retention time is the time at which the programme reaches that value (plus the delay from system volume). Change the slope and the retention time changes, even though the peptide has not changed. This is why a retention time only means something when it is quoted with its gradient. The related article on retention time covers this in more detail.
This also explains why two laboratories can report different purity for the same material. A different slope, column or acid can separate a different set of impurities. The article on why labs report different purity looks at that directly.
The practical costs of a gradient
Gradients solve the separation problem. They bring their own limits.
Baseline drift. Acetonitrile, water and the acid do not absorb UV light equally. TFA absorbs at the low wavelengths often used for peptides, commonly around 210 to 220 nm. As the proportion of B changes, the background absorbance changes, and the baseline rises or falls across the run. Balancing the acid concentration between A and B reduces the drift but rarely removes it. Drift matters because purity depends on integration, and integrating a small peak on a sloping baseline involves judgement.
Re-equilibration. After the gradient reaches its highest %B, the column must return to the starting composition and stabilise. Until it does, the next injection will not behave like the last one. Rules of thumb exist, usually expressed as a number of column volumes plus the system delay volume, but they differ between sources and are only starting points. The adequate time is confirmed for the specific column and instrument. Insufficient equilibration shows up as shifting retention times, especially for early peaks.
Dwell volume. The tubing and mixer between the pump and the column hold some liquid. The programmed gradient reaches the column late by that volume. Methods moved between instruments with different dwell volumes can show shifted retention even when the programme is identical.
Detector limits. A flat UV baseline is a convenience, not a requirement of the technique. A gradient can still give reliable quantitation, provided the baseline is handled consistently. The area percentage it gives, however, describes only what was detected. Components that do not absorb at the chosen wavelength, or that elute in the void or never leave the column, are not counted.
Where isocratic elution still fits
Isocratic elution has not been replaced. It is a good fit when:
- the sample holds a small number of components with similar retention;
- a simple, highly repeatable assay is wanted, with a flat baseline and short cycle times;
- the method is run very frequently and the lack of re-equilibration saves meaningful time;
- a particular pair of peaks needs to be separated, and the best %B for that pair has already been found.
Isocratic holds are also used inside gradients. A method may begin with a short hold at low %B to focus the sample, then ramp. Many gradient methods are a combination of both ideas.
For a peptide purity profile, though, the question being asked is "what else is in here, and how much?" The answer requires the widest practical window of retention. That is why a gradient is the default.
What this means for reading a certificate
A purity percentage is the output of a specific method. The gradient, the column, the acid, the detection wavelength and the integration settings all shaped it. A figure with none of that context cannot be compared with another figure.
When reading a report, look for whether the method conditions are stated, and whether the chromatogram is shown rather than only the number. The guide to reading a chromatogram explains what to check once you have it. Remember also that purity is a statement about composition in the sample submitted. It is not a statement about safety, and it says nothing about material that was not sampled.
Novagen is a third-party analytical laboratory. Certificates report what was measured in the sample submitted, and the certificate register at novagenlaboratories.com lets anyone verify one. Questions about methods can go to admin@novagenlaboratories.com.
Common questions
- What is the difference between gradient and isocratic elution?
In isocratic elution the mobile phase composition is constant for the whole run, for example 30% acetonitrile throughout. In gradient elution the proportion of organic solvent is increased over time, for example from 5% to 60% acetonitrile. Isocratic is simpler. Gradient handles samples whose components differ widely in how strongly they are retained, which is the normal situation for peptides.
- Why is gradient elution used for peptides?
Peptide retention in reversed-phase HPLC is very sensitive to the organic solvent concentration. A small change in %B can move a peptide from strongly retained to barely retained. A sample also usually contains the target peptide plus related impurities, such as truncated or modified sequences, that differ in hydrophobicity. A gradient lets each component elute as a narrow peak at a suitable %B. An isocratic run tends to give broad, late peaks or crowded early ones.
- What is isocratic elution best for?
Isocratic elution suits samples where the components have similar retention, and where simplicity and baseline stability matter. Examples include routine assays of a single small molecule, or a check of a few closely related compounds. It needs no re-equilibration between injections and gives a flat, stable UV baseline. It is rarely suitable for a peptide purity profile with a wide spread of impurities.
- Does the gradient affect peptide purity results?
Yes. Purity by HPLC is the main peak area as a fraction of total integrated area, and that depends on what separates and what is detected. A steep gradient can merge an impurity into the main peak. A shallow gradient can separate it and lower the reported purity. Two valid methods can therefore return different figures for the same sample. The gradient is part of the measurement, not a neutral detail.
- What is re-equilibration in gradient HPLC?
After a gradient ends at a high %B, the column must be returned to the starting mobile phase and held there until it is stable again. This is re-equilibration. If it is cut short, the next injection starts from a different column state and retention times shift, especially for early peaks. The volume needed depends on the column and system, so it is verified for each method rather than assumed.